Market Overview

UPDATE: Valeant Pharmaceuticals Posts Upbeat Q4 Profit

Canada's Valeant Pharmaceuticals International Inc (NYSE: VRX) posted a fourth-quarter profit.

Valeant Pharmaceuticals posted a quarterly net income at $55.9 million, or $0.18 per share, versus a year-ago net loss of $31.1 million, or $0.10 per share. Its revenue climbed 34% to $688.5 million. Its adjusted cash income came in at $297.7 million, or $0.94 per share.

Analysts were expecting earnings of $0.85 per share.

VRX shares closed at $47.93 on Friday.

Posted-In: EarningsEarnings News

 

Most Popular

Related Articles (VRX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free